Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial.
Yu WangYuan KongHong-Yan ZhaoYuan-Yuan ZhangYa-Zhe WangLan-Ping XuXiao-Hui ZhangKai-Yan LiuXiao-Jun HuangPublished in: BMC medicine (2022)
This trial was registered at ClinicalTrials.gov as #NCT03967665.
Keyphrases
- open label
- phase iii
- phase ii
- endothelial cells
- bone marrow
- study protocol
- clinical trial
- stem cell transplantation
- transcription factor
- phase ii study
- high glucose
- peripheral blood
- hematopoietic stem cell
- randomized controlled trial
- double blind
- high dose
- placebo controlled
- radiation therapy
- genome wide analysis
- low dose